Murata M - Search Results

1

Selective HDAC6 Inhibition Has the Potential for Anti-Cancer Effect in Renal Cell Carcinoma.

Anraku T, Murata M, Kuroki H, Kazama A, Shirono Y, Tasaki M, Bilim V, Tomita Y. Anraku T, et al. Among authors: murata m. J Pers Med. 2024 Jun 30;14(7):704. doi: 10.3390/jpm14070704. J Pers Med. 2024. PMID: 39063958 Free PMC article.

2

Retroperitoneal extragonadal seminoma developed with acute lower inferior vena cava syndrome: A case report.

Murata M, Inui K, Ikeda Y, Hasegawa G, Nakagawa Y, Nishiyama T, Tomita Y. Murata M, et al. Urol Case Rep. 2018 Jul 5;20:72-74. doi: 10.1016/j.eucr.2018.07.004. eCollection 2018 Sep. Urol Case Rep. 2018. PMID: 30069432 Free PMC article. No abstract available.

3

Unicentric Castleman's disease located between the aorta and inferior vena cava: A case report.

Murata M, Nagano O, Hasegawa G, Ikeda Y, Nakagawa Y, Seki Y, Nishiyama T, Tomita Y. Murata M, et al. SAGE Open Med Case Rep. 2019 Apr 3;7:2050313X19839532. doi: 10.1177/2050313X19839532. eCollection 2019. SAGE Open Med Case Rep. 2019. PMID: 30984398 Free PMC article.

4

Spontaneous Passage of Left Ureteral Multiple Calculi from Caliceal Diverticular Calculi: A Case Report.

Inui K, Murata M, Nakagawa Y, Ikeda Y, Nishiyama T, Tomita Y. Inui K, et al. Among authors: murata m. J Endourol Case Rep. 2019 Mar 18;5(1):10-12. doi: 10.1089/cren.2018.0081. eCollection 2019. J Endourol Case Rep. 2019. PMID: 30989121 Free PMC article.

5

Enzalutamide-induced severe thrombocytopenia complicated by a seizure in a 76-year-old man with castration-resistant prostate cancer.

Murata M, Takizawa I, Maruyama R, Kasahara T, Hara N, Tomita Y. Murata M, et al. IJU Case Rep. 2018 Oct 31;2(1):9-11. doi: 10.1002/iju5.12025. eCollection 2019 Jan. IJU Case Rep. 2018. PMID: 32743361 Free PMC article.

6

Development of patient‑derived tumor organoids and a drug testing model for renal cell carcinoma.

Kazama A, Anraku T, Kuroki H, Shirono Y, Murata M, Bilim V, Ugolkov A, Saito K, Tomita Y. Kazama A, et al. Among authors: murata m. Oncol Rep. 2021 Oct;46(4):226. doi: 10.3892/or.2021.8177. Epub 2021 Sep 1. Oncol Rep. 2021. PMID: 34468011 Free PMC article.

7

Advanced Bladder Cancer: Changing the Treatment Landscape.

Bilim V, Kuroki H, Shirono Y, Murata M, Hiruma K, Tomita Y. Bilim V, et al. Among authors: murata m. J Pers Med. 2022 Oct 20;12(10):1745. doi: 10.3390/jpm12101745. J Pers Med. 2022. PMID: 36294884 Free PMC article. Review.

8

Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma.

Kazama A, Bilim V, Tasaki M, Anraku T, Kuroki H, Shirono Y, Murata M, Hiruma K, Tomita Y. Kazama A, et al. Among authors: murata m. Sci Rep. 2022 Nov 27;12(1):20386. doi: 10.1038/s41598-022-24437-6. Sci Rep. 2022. PMID: 36437290 Free PMC article.

9

Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells.

Shirono Y, Bilim V, Anraku T, Kuroki H, Kazama A, Murata M, Hiruma K, Tomita Y. Shirono Y, et al. Among authors: murata m. Curr Oncol. 2023 May 28;30(6):5350-5365. doi: 10.3390/curroncol30060406. Curr Oncol. 2023. PMID: 37366889 Free PMC article.

10

MicroRNAs as Potential Regulators of GSK-3β in Renal Cell Carcinoma.

Murata M, Bilim V, Shirono Y, Kazama A, Hiruma K, Tasaki M, Tomita Y. Murata M, et al. Curr Issues Mol Biol. 2023 Sep 11;45(9):7432-7448. doi: 10.3390/cimb45090470. Curr Issues Mol Biol. 2023. PMID: 37754254 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,295 results

Search Page

Filters